1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elias, PM; Feingold, KR; Jain, M; Mao-Qiang, M | 1 |
1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Hyperplasia
| Article | Year |
|---|---|
Secretory phospholipase A2 activity is required for permeability barrier homeostasis.
Topics: Acetophenones; Animals; Cell Membrane Permeability; Enzyme Inhibitors; Epidermis; Glycerophosphates; Homeostasis; Hyperplasia; Lipid Metabolism; Male; Mice; Mice, Hairless; Phospholipases A; Phospholipases A2; Skin; Staining and Labeling | 1996 |